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Alkaptonuria (AKU) is caused by homogentisate 1,2-dioxygenase (HGD) defi-
ciency. This study aimed to determine if HGD and other enzymes related to tyro-
sine metabolism are associated with the location of ochronotic pigment. Liver,
kidney, skin, bone, brain, eyes, spleen, intestine, lung, heart, cartilage, and muscle
were harvested from 6 AKU BALB/c Hgd−/− (3 females, 3 males) and 4 male
C57BL/6 wild type (WT) mice. Hgd, 4-hydroxyphenylpyruvate dioxygenase (4-
Hppd), tyrosine hydroxylase (Th), and tyrosinase (Tyr) mRNA expression was
investigated using qPCR. Adrenal gland and gonads from AKU Hgd tm1a −/−
mice were LacZ stained, followed by qPCR analysis of Hgd mRNA. The liver had
the highest expression of Hgd, followed by the kidney, with none detected in carti-
lage or brain. Low-level Hgd expression was observed within developing male
germ cells within the testis and epididymis in Hgd tm1a −/−. 4-Hppd was most
abundant in liver, with smaller amounts in kidney and low-level expression in
other tissues. Th was expressed mainly in brain and Tyr was found primarily in
the eyes. The tissue distribution of both Hgd and 4-Hppd suggest that ochronotic
pigment in AKU mice is a consequence of enzymes within the liver, and not from
enzymatic activity within ochronotic tissues. Excessive accumulation of HGA as
ochronotic pigment in joints and other connective tissues originates from the circu-
lation and therefore the extracellular fluid. The tissue distribution of both Th and
Tyr suggests that these enzymes are not involved in the formation of HGA-derived
ochronotic pigment.
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1 | INTRODUCTION
Alkaptonuria (AKU; OMIM #203500) is a rare, autoso-
mal recessive disorder of tyrosine metabolism (Figure 1)
caused by the lack of homogentisate 1,2-dioxygenase
(HGD; EC 1.13.11.5).1 In the absence of HGD,
homogentisic acid (HGA) is excreted in the urine of AKU
patients, however this does not remove all excess HGA
from the body. AKU is characterized by increased HGA
in the plasma and therefore the body tissues, where it is
thought to be oxidized and polymerized into a pigment
causing ochronosis.2 Ochronotic pigment is deposited in
the extracellular matrices and intracellular compartment
of cells of connective tissues over time, especially in carti-
lage, leading to early onset and severe degenerative
pathology in load bearing joints.3 In addition to joint
manifestations, scleral eye pigmentation, tendon and
muscle rupture, valvular heart disease and kidney stones
and gallstones are features of AKU.4
The pathophysiological mechanism of ochronosis is cur-
rently unknown. Both HGD and 4-hydroxyphenylpyruvate
dioxygenase (4-HPPD; EC 1.13.11.27), another enzyme in
the tyrosine metabolic pathway, have been implicated in
tissue localization of ochronotic pigment.5 It has been
hypothesized that the absence of functional HGD enzyme
and the expression of 4-HPPD within localized tissue
sites of ochronotic pigment deposition are its main cause,
as 4-HPPD converts 4-hydroxyphenylpyruvate to HGA
and HGD converts this to maleylacetoacetate (Figure 1).
Due to the potential similarity of ochronotic pigment to
melanin, both tyrosinase (TYR; EC 1.14.18.1) and tyro-
sine hydroxylase (TH; EC 1.14.16.2) have been implicated
in ochronosis. TYR is involved in melanin production
and has been hypothesized to act nonspecifically with
HGA to form ochronotic pigment seen in AKU patients
within specific tissue sites.6 TYR is located in melano-
cytes and is important in the production of the pigment
melanin within hair, skin and eyes. TH is involved in
melanin production as an intermediate enzyme, responsi-






1,2-dioxygenase (HGD) are involved in
the metabolism of tyrosine to fumaric
acid. Tyrosine hydroxylase (TH) is
involved in the process of converting
tyrosine to catecholamines and
tyrosinase (TYR) in melanin production.
The pathway to ochronotic pigment is
shown (dashed arrows). Enzymes are in
italics
Synopsis
Homogentisic acid accumulation in con-
nective tissues of alkaptonuria patients is a
consequence of the enzymes within the
liver and not local enzymatic production at
affected sites.
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The aim was to determine whether production of
HGA and its subsequent deposition as an ochronotic pig-
ment (whether this be as HGA itself or as HGA-derived
pigment), is a result of local tissue enzymes in sites of
ochronosis involved in tyrosine metabolism or as a result
of excessive accumulation of HGA from the circulation to
the extracellular fluid. Here a survey of 4 specific
enzymes was conducted on tissues from albino BALB/c
Hgd−/− AKU mice (Mus musculus).7 These mice have
liver HGD activity of <6% of normal wild type
(WT) mice,8 which results in increased plasma HGA at
approximately 150 μmol/L and subsequent ochronosis of
articular cartilage.7,9 A point mutation (T to A, nt 1178)
at the splice donor sequence of intron 12, leading to exon
12 deletion and a frameshift mutation and premature
stop codon at the start of exon 13, severely truncating the
protein.10,11 To show that the tissue distribution of
enzymes is not affected by albinism and the AKU defect,
tissues from C57BL/6 WT mice that have a dark brown
coat were also examined. Additional LacZ staining data
is shown from a different mouse model of AKU, Hgd
tm1a −/−, in tissues that had not been investigated
previously.12
2 | METHODS
All mice were housed and maintained within the University
of Liverpool's Biological Services Unit (BSU) in accordance
with Home Office UK guidelines. All mice were culled by
cervical dislocation. Tissues were harvested for mRNA anal-
ysis from 6 BALB/c Hgd−/− (3 females, aged 56 weeks
(n = 2) and 34 weeks (n = 1); 3 males, 21 weeks (n = 3))
and 4 C57BL/6 WT (male; aged 16 weeks (n = 3) and
18 weeks (n = 1)) mice (referred to as AKU and WT, respec-
tively), which included liver, kidney, skin, bone, brain, eyes,
spleen, intestine, lung, heart, cartilage, and muscle. The car-
tilage and eye samples were each pooled for analysis,
grouped by gender. Liver, testis and epididymis tissue from
Hgd tm1a −/− (3 males, aged 13.9 weeks) was harvested for
mRNA analysis. All tissues appeared normal in color. Tis-
sues were immediately placed into 5-10 volumes of
RNAlater solution/tissue volume (Life Technologies) and
stored overnight at 4C. For long term storage, the RNAlater
solution was removed, tissue dried and stored at −80C.
Approximately 35 mg of tissue was lysed using the
MP FastPrep 24 with Matrix D and Matrix M (bone and
cartilage) beads in 1 mL QIAZOL (Invitrogen). Seven
hundred microliters of lysate was then removed for total
RNA purification using the QIAGEN RNeasy mini kit,
with a DNase digestion step. RNA concentration was
measured using a NanoDrop Spectrophotometer
(Thermo Scientific) and cDNA produced through High
Capacity RNA-to-cDNA kit (Applied Biosystems). qPCR
was performed on a Bio-Rad CFX Connect Real-Time
PCR Detection System with SsoAdvanced Universal
SYBR Green Supermix (Bio-Rad Laboratories), with the
exception of the tissues in Figure 4D, for which iQ SYBR
Green Supermix was used (Bio-Rad Laboratories).
Primers were custom designed for mouse Hgd 50-
TGTCCACGGAACACCAATAA-30 50-GCCAACTTCAT-
CCCAGTTGT-30, 4-Hppd 50-ATCGCTCTCAAGACGG-
AAGA-30 50-TGAGATTCTCCCGAAGCAGT-30, Th 50-
TGTGGAGTTTGGGCTGTGTA-30 50-AGCTTGTCCTT-
GGCATCACT-30, Tyr 50-CCTCCTGGCAGATCATTTGT-
30 50-CTGGCAAATCCTTCCAGTGT-30, and 18S 50-
GAAAATAGCCTTCGCCATCA-30 50-AGTTCTCCAGC-
CCTCTTGGT-30 (reference gene).
Whole tissues from Hgd tm1a −/− mice were LacZ
stained overnight to determine expression of Hgd. Hgd
tm1d (fl/fl) MxCre WT12 mice were used as a LacZ nega-
tive control. Adrenal gland, ovary and uterus from
13-week Hgd tm1a and 6-week Hgd tm1d MxCre. Testis
and epididymis from 16-week Hgd tm1a and 23-week
Hgd tm1d MxCre. Briefly, tissues were dissected, rinsed in
PBS, fixed (2% paraformaldehyde, 0.2% glutaraldehyde,
0.1 M sodium phosphate buffer [pH 7.4], 5 mM EGTA
and 2 mM MgCl2 in dH20) on ice, washed 3 × 30 minutes
in rinse solution (0.1 M sodium phosphate buffer
[pH 7.4], 2 mM MgCl2, 0.1% sodium deoxycholate and
0.2% NP40 in dH20) while rotating, then LacZ stained
(1 mg/mL X-gal (5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside), 5 mM potassium ferricyanide, 5 mM
potassium ferrocyanide in rinse solution) overnight in
the dark while rotating. Post-staining, tissues were fixed
in formalin, paraffin embedded and sectioned.
Statistical analysis was performed using GraphPad
Prism 6 statistical software. One-way ANOVA followed
by Tukey's multiple comparisons test was used to look
for differences in enzyme expression between the differ-
ent tissues. Error bars represent SE of the mean.
3 | RESULTS
Hgd mRNA was detected mainly in the liver and kidney
but also observed in the eyes in both strains of mice and
in the lung of the WT (Figure 2A,B). For both strains of
mice, liver and kidney expression was significantly
greater than all other tissues (P < .0001), and in AKU
mice liver Hgd expression was significantly greater than
kidney (P < .05). In the eyes and lung, expression was
extremely low, with no expression detected in either car-
tilage or other tissues. Hgd expression was nearly
1000-fold greater in the liver compared to the eyes in
AKU mice and >3000-fold than WT eyes.
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FIGURE 2 Expression of Hgd and 4-Hppd. A and B, Hgd and, C and D, 4-Hppd mRNA expression in different tissues from AKU
(A and C) and WT (B and D) mice
FIGURE 3 Expression of Th and Tyr. A and B, Th and, C and D, Tyr mRNA expression in different tissues from AKU (A and C) and
WT (B and D) mice
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4-Hppd mRNA was primarily found in liver with
smaller amounts observed in the kidney and intestine, with
extremely low expression in cartilage, bone (AKU mice),
brain, spleen, eyes (AKU mice; female only), lung, heart,
and muscle (Figure 2C,D). 4-Hppd expression in liver was
significantly greater than all other tissues (P < .0001) in
both strains of mice, while kidney expression was also sig-
nificantly higher than all other tissues (P < .01) in AKU
mice, with >100-fold expression over the intestine. For both
strains of mice, liver 4-Hppd expression was >1500-fold
greater than all other tissues in which expression was
observed (excluding the kidney and intestine), with expres-
sion in AKU mouse cartilage >15 000-fold less.
Th mRNA was found primarily in the brain, with
smaller amounts observed in the eyes, skin, intestine,
heart (AKU mice) and kidney (WT mice) (Figure 3A,B).
In both strains of mice, brain Th expression was signifi-
cantly greater than other tissues (P < .0001). No expres-
sion was detected in the cartilage or other tissues
examined. Tyr mRNA was mainly found in the eyes, sig-
nificantly higher than other tissues (P < .0001), with
small amounts observed in the skin and brain, and no
expression in cartilage or any other tissue in both strains
of mice (Figure 3C,D).
Ex vivo staining of tissues from Hgd tm1a −/− which
has a LacZ reporter gene situated within the fifth Hgd
intron previously demonstrated Hgd expression in the
liver and kidney proximal convoluted tubule cells, with
no expression in brain, heart, lung, muscle, spleen, intes-
tine, skin, bone, cartilage, eye, and prostate.12 Here, LacZ
FIGURE 4 Expression of
Hgd within developing male
germ cells within the testis and
epididymis. The testis, A, and
epididymis, B, from Hgd tm1a
−/− and Hgd tm1d MxCre WT
(LacZ negative control) were
LacZ stained. Arrows in
(B) represent false-positive LacZ
staining. The cell types within
the wall of the seminiferous
tubules within the testis are
identified in (C). Hgd mRNA
expression within the liver,
testis and epididymis of Hgd
tm1a −/− mice is shown in (D).
ES, elongated spermatozoa; My,




Nuclear fast red counterstain in
(A–C). Scale bar = 50 μm
WILSON ET AL. 5
staining of adrenal gland, ovary and uterus from Hgd
tm1a −/− was negative, confirmed with histological sec-
tioning (data not shown), indicating that Hgd is not
expressed in these tissues. LacZ staining of testis and epi-
didymis however showed positive blue LacZ staining in
Hgd tm1a −/− (Figure 4A,B). The staining at the luminal
edge of the epididymal tubules (indicated by arrows,
Figure 4B) is false-positive, as it was also observed in the
LacZ negative control (Hgd tm1d (fl/fl) MxCre WT), and
therefore does not represent Hgd expression. There was
however positive staining observed within the epididymal
tubule lumen in Hgd tm1a −/−, that was not observed
in the control. The positive staining observed in
the testis appears to be localized to the cytoplasm of
developing male germ cells that migrate through the
seminiferous tubules, specifically within secondary sper-
matocytes, round spermatids and elongated spermatozoa
(Figure 4C). The diffuse punctate dots of staining near
the basal edge of the seminiferous tubules may be due to
cytoplasmic residual bodies that are shed from elongating
spermatozoa, which are then phagocytosed by the
somatic Sertoli cells. The staining within the epididymis
is therefore likely to be within the cytoplasm of maturing
spermatozoa. Hgd mRNA expression (Figure 4D) in the
liver of Hgd tm1a −/− mice was approximately 7600-fold
and 2000-fold greater than in the testis and epididymis,
respectively.
4 | DISCUSSION
The purpose of this study was to identify whether
enzymes involved in tyrosine metabolism are responsible
for local production of pigment at specific tissue sites.
Additionally, identifying the tissues where HGA is pro-
duced and metabolized may help target future treatments
of AKU. This becomes more problematic if these
enzymes are identified in tissues such as cartilage and
brain, which has been previously suggested for HGD.5,13
Articular cartilage is avascular, and due to the molecular
composition of its extracellular matrix, mainly collagens
and proteoglycans, it is a dense, highly anionic tissue,
making drug diffusion slow and difficult to penetrate to
the calcified cartilage, where initial pigmentation
occurs,14 at a therapeutic concentration. A different chal-
lenge arises when attempting to target the brain; thera-
peutic molecules are required to pass through the blood-
brain barrier, which prevents both large molecules and
molecules with net electric charge passing. Here we show
the location of Hgd expression in mice is located in the
liver and kidney, along with 4-Hppd, and rule out the
involvement of melanin-producing enzymes in the patho-
physiology of AKU.
AKU patients typically become symptomatic around
the fourth decade of life, presenting with progressive
arthritic pain in weight bearing joints such as the spinal
column, knees, and hips. It is common for patients to
require multiple arthroplasty, with an average age of
approximately 50 years for joint replacement surgery.4
Cartilage is the most affected tissue in AKU patients, so it
would be reasonable to suggest that if enzymes involved
in tyrosine metabolism are responsible for ochronotic
pigment, that they may be detected in articular cartilage.
4-HPPD and HGD, investigated here in mice, are
enzymes involved in the metabolic process of breaking
down tyrosine to fumaric acid and acetoacetic acid and
have been previously reported in the liver and kid-
ney.1,15-17 It has been speculated that HGD is present but
nonfunctional within AKU ochronotic tissues and is the
cause of pigmentation.5 Significant Hgd mRNA expres-
sion however was not detected in sites of pigmentation
such as articular cartilage here in mice, but was detected
in both the liver and kidney as expected. Even though
kidney Hgd expression is relatively high, intact kidney
Hgd expression was unable to reduce plasma HGA in a
conditional AKU mouse model after liver-specific Hgd
deletion, indicating that liver Hgd is crucial for HGA
metabolism.12 Furthermore, a case report by Kobak
et al18 reported an AKU patient's urine to be absent of
HGA after a liver transplant, in addition to a halt in dis-
ease progression. Hgd has not been detected before in
lung12,17 or eyes12; the expression here observed was
extremely low in these tissues, and it is not known if pro-
tein or active enzyme is present. There is no anticipated
function for HGD within tissues such as the lung, conse-
quently there could conceivably be a mechanism for
downregulation of signal such as interference with
siRNA's. Reports have suggested HGD expression in the
brain13 as well as in chondrocytes and osteoblasts.5 Con-
flicting results are presented here, with no Hgd mRNA
observed in the brain, bone or cartilage. Furthermore,
northern blot analysis of HGD in human tissues also
demonstrated no expression in brain (cartilage/bone not
investigated).17 They did however observe HGD in the
prostate, small intestine and colon.17 The LacZ reporter
gene within the Hgd tm1a −/− mouse model previously
found no Hgd expression within the eyes, lungs, brain,
bone/cartilage, prostate and intestine.12 Here the LacZ
reporter gene was used to investigate Hgd expression
within the adrenal gland, ovary, uterus, testis and epidid-
ymis as they had not previously been investigated.12
Hgd expression was detected by LacZ staining within
the cytoplasm of developing male germ cells within the
testis and epididymis and not within the somatic cells.
Within the seminiferous tubules, germ cells undergo
spermatogenesis as they move from the basal surface of
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the Sertoli cell ending up as elongated, motile spermato-
zoa at the luminal edge.19,20 During this process, cyto-
plasm is shed, leaving behind a cytoplasmic droplet in
the cell; these are believed to have a role in energy
metabolism essential for epididymal sperm matura-
tion.20,21 Downstream metabolites of HGA include
fumaric acid and acetoacetic acid, which can both enter
the TCA cycle and also be used for gluconeogenesis and
ketogenesis, respectively. It could therefore be hypothe-
sized that Hgd expression in maturing sperm a role in
energy metabolism, with Hgd expression then down-
regulated in mature sperm—Hgd was not previously
detected in the prostate via LacZ staining.12 Compared to
the liver, very low Hgd expression in developing germ
cells suggests that it is very unlikely to contribute toward
metabolism of the circulating HGA pool in AKU, and is
therefore likely to have no effect on pigmentation.
It has been speculated that 4-HPPD is present and
functional within AKU ochronotic tissues producing
HGA.5 4-Hppd mRNA was most abundant in liver, with
a smaller amount found in the kidney, with low expres-
sion detected in most other tissues. In humans, the skin
is another site of ochronotic pigment deposition; the lack
of 4-Hppd mRNA here in skin and extremely low expres-
sion in cartilage, approximately 15 000-fold less than liver
in AKU mice, demonstrates that HGA present within
these tissues is most likely due to circulating HGA pro-
duced by the liver. This finding is corroborated by Lin
and Knox (1958), who demonstrated that liver 4-HPPD
activity greatly exceeded that of the kidney, with no sig-
nificant expression in other tissues such as brain, lung,
muscle and spleen within the rat.15 In 1972, Fellman et al
reported 4-HPPD activity in mammalian liver and kidney
but not in heart, muscle or brain.22 The very low mRNA
expression reported here within these tissues may not be
enough for detectable protein or enzyme activity. Earlier
studies have shown 4-Hppd mRNA to be present in the
rat brain23 but with no enzyme activity observed in the
rat, monkey and human brain.22
The abundance of these enzymes in both the liver
and kidney, especially the liver, would suggest these
organs have the capacity to metabolize the tyrosine load
of the whole organism. The expression of Hgd and
4-Hppd here suggest that the ochronotic pigment found
in AKU tissues is a consequence of the enzymes within
the liver, affecting circulating metabolite levels that equil-
ibrates to extracellular fluid surrounding all tissues. The
liver appears to be the primary target organ for HGD
replacement in AKU. Recently, it has been demonstrated
that isotopically-labeled HGA injected into the blood-
stream of non-AKU mice can be taken-up and metabo-
lized by Hgd-expressing cells which is crucial for HGD-
replacement therapies to work effectively.12 As previously
stated by La Du in 1998,24 replacement of HGD needs to
be approached with caution, as the sequential steps in
the tyrosine pathway produces highly reactive intermedi-
ate metabolites (maleylacetoacetate/fumarylacetoacetate/
succinylacetoacetate; MAA/FAA/SAA) that must be rap-
idly metabolized to prevent severe liver and renal tissue
damage as observed in hereditary tyrosinaemia type I
(OMIM #276700) where these metabolites accumulate
due to fumarylacetoacetate hydrolase (FAH; EC 3.7.1.2)
deficiency. Restoring HGD activity outside of the liver
could therefore cause tissue damage. La Du previously
demonstrated in human AKU liver that FAH was
expressed at a normal level,1 which provides confidence
that restoring HGD activity in the liver would not cause
further pathology.
HGA has been shown to oxidize to benzoquinone acetic
acid (BQA) turning solutions and tissues black.25 Although
ochronotic pigmentation has been associated with
collagen,26-28 the mechanism of ochronotic pigmentation is
unknown. It is thought that ochronotic pigment could be
formed due to the oxidation of HGA to BQA as an interme-
diate step, although it is not known whether initial binding
to collagenous matrix occurs as HGA, the BQA intermedi-
ate or as ochronotic pigment itself.29 A recent study using
NMR and EPR spectroscopy suggests that formation of
hydroquinones and radicals that causes collagen degrada-
tion in AKU cartilage.30 As the mechanism for ochronotic
pigment formation in AKU is not known, the TH and TYR
enzymes involved in the pathway for melanin production, a
compound thought to be similar to ochronotic pigment,
were examined for their possible role. Th was expressed
mainly in the brain, involved in the production of catechol-
amine neurotransmitters, adrenaline, noradrenaline and
dopamine, which are essential for normal brain function,
control of physical movement and emotional behavior.31
TH has been previously identified in the retina,32 heart33
and kidney34 of mice, and intestine35 and skin36 of guinea
pigs, due to association with the sympathetic nerves37
within these tissues. Th was observed to a lesser degree in
some of the tissues studied here, but not detected in carti-
lage. TYR is responsible for the first step in melanin produc-
tion, found in the retinal pigmented epithelium of the eye
and melanocytes of skin. Expression of Tyr observed in the
eyes and skin was therefore expected, which has been previ-
ously reported.38 Expression was also observed in the brain
here, which has previously been under debate.39,40 No
expression was seen in other tissues, including cartilage. It
is clear that from the tissue distribution observed of both Th
and Tyr, that these enzymes are not involved in the forma-
tion of HGA-derived ochronotic pigment at sites of
ochronosis.
Ochronotic pigment is a result of exposure to high
concentrations of HGA within extracellular fluid that is
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at equilibrium with the blood due to liver deficiency of
Hgd, rather than through local production from enzymes
within the affected tissues. The tissue distribution of Hgd,
4-Hppd, Th, and Tyr illustrates that these enzymes are
unlikely to be involved in the local formation/deposition
of ochronotic pigment within connective tissues such as
cartilage.
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